Current Status of the Immunomodulation and Immunomediated Therapeutic Strategies for Multiple Sclerosis
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system, and CD4+ T cells form the core immunopathogenic cascade leading to chronic inflammation. Traditionally, Th1 cells (interferon-γ-producing CD4+ T cells) driven by interleukin 12 (IL12) were considered to be the encephalit...
Saved in:
Main Authors: | Shyi-Jou Chen, Yen-Ling Wang, Hueng-Chuen Fan, Wen-Tsung Lo, Chih-Chien Wang, Huey-Kang Sytwu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2012/970789 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunologic Regulation in Pregnancy: From Mechanism to Therapeutic Strategy for Immunomodulation
by: Shyi-Jou Chen, et al.
Published: (2012-01-01) -
Immunomediated Encephalitis: New Diagnoses on the Neurology–Psychiatry Interface
by: Daniel Damiani, et al. -
Rodent Models for Investigating the Dysregulation of Immune Responses in Type 1 Diabetes
by: Feng-Cheng Chou, et al.
Published: (2013-01-01) -
Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis
by: Wassim Elyaman, et al.
Published: (2011-01-01) -
Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics
by: Peter S. Kim, et al.
Published: (2015-03-01)